Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Epileptic Seizure in Epilepsy Patients After First-dose Inactivated SARS-CoV-2 Vaccination: a Self-controlled Case Series Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05341713
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:41.740740+00:00
Published At
2022-04-22T00:00:00+00:00
Record Updated At
2022-04-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Epileptic Seizures Related to Drugs", "SARS-CoV-2 Acute Respiratory Disease", "Vaccine Adverse Reaction"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-04-22"
protocolSection.identificationModule.nctId
"NCT05341713"
protocolSection.identificationModule.officialTitle
"Epileptic Seizure in Epilepsy Patients After First-dose Inactivated SARS-CoV-2 Vaccination: a Self-controlled Case Series Study"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Epileptic Seizures Related to Drugs (protocolSection.conditionsModule.conditions)
  • SARS-CoV-2 Acute Respiratory Disease (protocolSection.conditionsModule.conditions)
  • Vaccine Adverse Reaction (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.